Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia

Background/aim: The present study aimed to determine the association between attention-deficit hyperactivity disorder (ADHD) symptoms severity, fibromyalgia (FM) severity, and QoL. Materials and methods: While the FM group consisted of 113 (74%) patients, the control group consisted of 40 (26%) individuals. FM symptom severity, ADHD symptom severity, and QoL were evaluated using the fibromyalgia impact questionnaire (FIQ), adult ADHD self-report scale (ASRS), and World Health Organization quality of life scale-brief version (WHOQOL-BREF), respectively. Results: It was found that the FM group had significantly higher scores on the ASRS than the control group (p < 0.05). There was a significant difference in FIQ scores and three WHOQOL-BREF domain scores between the FM alone and comorbid FM/high probability of ADHD groups (p < 0.05). We found a negative correlation between ASRS total scores and all other scale scores (except for the social relationships domain score of the WHOQOL-BREF) and a positive correlation between ASRS total scores and FIQ scores in FM patients. ADHD scores would mediate the relationship between depression severity and QoL. Conclusions: Our findings indicated that the presence of ADHD symptoms was related to greater FM symptom severity and poorer QoL. Also, ADHD scores would mediate the relationship between depression severity and QoL.Key words: Adult attention deficit hyperactivity disorder, fibromyalgia, quality of life

PDF

___

1. Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 2007; 164 (6): 942-948. doi: 10.1176/appi.ajp.164.6.942
2. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 2006; 36 (2): 159- 165. doi: 10.1017/S003329170500471X
3. Jensen CM, Steinhausen H-C. Comorbid mental disorders in children and adolescents with attention-deficit/ hyperactivity disorder in a large nationwide study. ADHD Attention Deficit and Hyperactivity Disorders 2015; 7 (1): 27-38. doi: 10.1007/ s12402-014-0142-1
4. Brainstorm C, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK et al. Analysis of shared heritability in common disorders of the brain. Science 2018; 22;3 60 (6395): eaap8757. doi: 10.1126/science.aap8757
5. Treister R, Eisenberg E, Demeter N, Pud D. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD). Pain Practice 2015; 15 (1): 4-11. doi: 10.1111/papr.12129
6. Clauw DJ. Fibromyalgia and related conditions. Mayo Clinic Proceedings 2015; 90 (5): 680-692. doi: 10.1016/j. mayocp.2015.03.014
7. Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. JCR: Journal of Clinical Rheumatology 2006; 12 (3): 124-128. doi: 10.1097/01.rhu.0000221817.46231.18
8. Cabo-Meseguer A, Cerdá-Olmedo G, Trillo-Mata JL. Fibromyalgia: prevalence, epdemiologic profiles and economic costs. Medicina Clinica 2017; 149 (10): 441-448. doi: 10.1016/j. medcli.2017.06.008
9. Queiroz LP. Worldwide epidemiology of fibromyalgia. Current Pain and Headache Reports 2013; 17 (8): 356. doi: 10.1007/ s11916-013-0356-5
10. Goldenberg D, Schur P, Romain P. Clinical manifestations and diagnosis of fibromyalgia in adults. Literature Review UpToDate 2016.
11. Buskila D, Sarzi-Puttini P. Biology and therapy of fibromyalgia, genetic aspects of fibromyalgia syndrome. Arthritis Research & Therapy 2006; 8 (5): 218. doi: 10.1186/ar2005
12. Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Research and Treatment 2012; 2012: 1-17. doi: 10.1155/2012/426130
13. Jay GW, Barkin RL. Fibromyalgia. Disease-A-Month 2015; 61 (3): 66-111. doi: 10.1016/j.disamonth.2015.01.002
14. Consoli G, Marazziti D, Ciapparelli A, Bazzichi L, Massimetti G et al. The impact of mood, anxiety, and sleep disorders on fibromyalgia. Comprehensive Psychiatry 2012; 53 (7): 962-967. doi: 10.1016/j.comppsych.2012.03.008
15. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosomatic Medicine 2004; 66 (6): 837-844. doi: 10.1016/j.comppsych.2012.03.008
16. Glass JM. Cognitive dysfunction in fibromyalgia and chronic fatigue syndrome: new trends and future directions. Current Rheumatology Reports 2006; 8 (6): 425-429. doi: 10.1007/ s11926-006-0036-0
17. Tesio V, Torta DM, Colonna F, Leombruni P, Ghiggia A et al. Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care & Research 2015; 67 (1): 143-150. doi: 1-.1002/acr.22403
18. Montoro CI, Duschek S, Muñoz Ladrón de Guevara C, Fernández-Serrano MJ, Reyes del Paso GA. Aberrant cerebral blood flow responses during cognition: Implications for the understanding of cognitive deficits in fibromyalgia. Neuropsychology 2015; 29 (2): 173-182. doi: 10.1037/ neu0000138
19. Katz RS, Heard AR, Mills M, Leavitt F. The prevalence and clinical impact of reported cognitive difficulties (fibrofog) in patients with rheumatic disease with and without fibromyalgia. JCR: Journal of Clinical Rheumatology 2004; 10 (2): 53-58. doi: 10.1097/01.rhu.0000120895.20623.9f
20. Zachrisson O, Regland B, Jahreskog M, Kron M, Gottfries CG. A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale). Journal of Psychosomatic Research 2002; 52 (6): 501-509. doi: 10.1016/S0022-3999(01)00315-4
21. Turjanski N, Lees A, Brooks D. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52 (5): 932-937. doi: 10.1212./ wnl.52.5.932
22. Lopez R, Micoulaud Franchi J-A, Chenini S, Gachet M, Jaussent I et al. Restless legs syndrome and iron deficiency in adults with attention-deficit/hyperactivity disorder. Sleep 2019; 42 (5): 1-26. doi: 10.1093/sleep/zsz027
23. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. British Medical Journal 1996; 312 (7042): 1339. doi: 10.1136/bmj.312.7042.1339
24. Vorobeychik Y, Acquadro MA. Use of atomoxetine in a patient with fibromyalgia syndrome and attention-deficit hyperactivity disorder. Journal of Musculoskeletal Pain 2008; 16 (3): 189-192. doi: 10.1080/10582450802161960
25. Kessler R1C, Adler L, Ames M, Demler O, Faraone S et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychological Medicine 2005; 35 (2): 245-256. doi: 10.1017/ S0033291704002892
26. Dogan S, Öncü B, Varol-Saraçoglu G, Küçükgöncü S. Validity and reliability of the Turkish version of the Adult ADHD SelfReport Scale (ASRS-v1.1). Anatolian Journal of Psychiatry 2009; 10 (2): 77-87.
27. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. Journal of Rheumatology 1991; 18 (5): 728-733.
28. Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatology International 2000; 20 (1): 9-12. doi: 10.1007/ s002960000077
29. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983; 67 (6): 361-370. doi: 10.1111/j.1600-0447.1983.tb09716.x
30. Aydemir Ö, Guvenir T, Kuey L, Kultur S. Validity and reliability of Turkish version of hospital anxiety and depression scale (in Turkish). Turkish Journal of Psychiatry 1997; 8 (4): 280-287.
31. Eser SY, Fidaner H, Fidaner C, Elbi H, Eser E, Göker E. Yaşam kalitesinin ölçülmesi, WHOQOL-100 ve WHOQOL-Bref. Journal of Psychiatry Psychology Psychopharmacology 1999; 7 (2): 5-13.
32. Preacher KJ, Hayes AF. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behavior Research Methods 2008; 40 (3): 879-891. doi: 10.3758/BRM.40.3.879
33. Hayes AF. Mediation, moderation, and conditional process analysis. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York, Guilford Publications, 2013.
34. Sobel ME. Some new results on indirect effects and their standard errors in covariance structure models. Sociological Methodology 1986; 16: 159-186. doi: 10.2307/270723
35. Golimstok A, Fernandez M, Garcia Basalo M. Adult attentiondeficit and hyperactivity disorder and fibromyalgia: a casecontrol study. Neuro Open Journal 2015; 2 (2): 61-66. doi: 10.17140/NOJ-2-114
36. Moore DJ, Keogh E, Eccleston C. The interruptive effect of pain on attention. The Quarterly Journal of Experimental Psychology 2012; 65 (3): 565-586. doi: 10.1080/17470218.2011.626865
37. Van Rensburg R, Meyer HP, Hitchcock SA, Schuler CE. Screening for adult ADHD in patients with fibromyalgia syndrome. Pain Medicine 2017; 19 (9): 1825-1831. doi: 10.1093/pm/pnx275
38. Derksen M, Vreeling M, Tchetverikov I. High frequency of adult attention deficit hyperactivity disorder among fibromyalgia patients in the Netherlands: should a systematic collaboration between rheumatologists and psychiatrists be sought? Clinical and Experimental Rheumatology 2015; 33 (1 Suppl 88): 141.
39. Dan B, Hagit C, Lily N, Ebstein R. An association between fibromyalgia and the dopamine D4 receptor exon III repeat polymorphism and relationship to novelty seeking personality traits. Molecular Psychiatry 2004; 9 (8): 730-731. doi: 10.1038/ sj.mp.4001506
40. Shaw P, Gornick M, Lerch J, Addington A, Seal J et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Archives of General Psychiatry 2007; 64 (8): 921-931. doi: 10.1001./archpsyc.64.8.921
41. Bou Khalil R, Khoury E, Richa S. Do fibromyalgia flares have a neurobiological substrate? Pain Medicine 2016; 17 (3): 469- 475. doi: 10.1093/pm/pnw008
42. Cortese S. The neurobiology and genetics of attention-deficit/ hyperactivity disorder (ADHD): what every clinician should know. European Journal of Paediatric Neurology 2012; 16 (5): 422-433. doi: 10.1016/j.ejpn.2012.01.009
43. Duschek S, Werner NS, Limbert N, Winkelmann A, Montoya P. Attentional bias toward negative information in patients with fibromyalgia syndrome. Pain Medicine 2014; 15 (4): 603- 612. doi: 10.1111/pme.12360
44. Dick BD, Verrier MJ, Harker KT, Rashiq S. Disruption of cognitive function in fibromyalgia syndrome. Pain 2008; 139 (3): 610-616. doi: 10.1016/j.pain.2008.06.017
45. Ambrose K, Gracely R, Glass J. Fibromyalgia dyscognition: concepts and issues. Reumatismo 2012: 206-215. doi: 10.4081/ reumatismo.2012.20
46. Eccleston C. Chronic pain and attention: a cognitive approach. British Journal of Clinical Psychology 1994; 33 (4): 535-547. doi: 10.1111/j.2044-8260.1994.tb01150.x
47. Glass JM. Fibromyalgia and cognition. The Journal of Clinical Psychiatry 2008; 69 (2): 20-24.
48. Karaş H, Çetingök H, İlişer R, Çarpar E, Kaşer M. Childhood and adult attention deficit hyperactivity disorder symptoms in fibromyalgia: associations with depression, anxiety and disease impact. International Journal of Psychiatry in Clinical Practice 2020; 24 (3): 257-263. doi: 10.1080/13651501.2020.1764585
49. Stefano P, Francesco P, Luana S. Adult attention deficit hyperactivity disorder in patients with fibromyalgia syndrome: assessment and disabilities. Journal of Psychiatric Research 2020 (in press). doi: 10.1016/j.jpsychires.2020.10.027
50. Gündüz N, Polat A, Erzincan E, Turan H, Sade I et al. Psychiatric comorbidity and childhood trauma in fibromyalgia syndrome. Turkish Journal of Physical Medicine and Rehabilitation 2018; 64 (2): 91-99. doi: 10.5606/tftrd.2018.1470
51. Fietta P, Manganelli P. Fibromyalgia and psychiatric disorders. Acta Bio-Medica: Atenei Parmensis 2007; 78 (2): 88-95.
52. De Souza JB, Potvin S, Goffaux P, Charest J, Marchand S. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. The Clinical Journal of Pain 2009; 25 (2): 123-127. doi: 10.1097/ AJP.0b013e318183cfa4
53. Lichtenstein A, Tiosano S, Amital H. The complexities of fibromyalgia and its comorbidities. Current Opinion in Rheumatology 2018; 30 (1): 94-100. doi: 10.1097/ BOR.0000000000000464
54. Christiansen H, Hirsch O, Albrecht B, Chavanon M-L. Attention-deficit/hyperactivity disorder (ADHD) and emotion regulation over the life span. Current Psychiatry Reports 2019; 21 (3): 1-11. doi: 10.1007/s11920-019-1003-6